Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Seres Therapeutics (MCRB) Amortizatization of Intangibles: 2016-2023

Historic Amortizatization of Intangibles for Seres Therapeutics (MCRB) over the last 8 years, with Dec 2023 value amounting to $236,000.

  • Seres Therapeutics' Amortizatization of Intangibles rose 120.94% to $49,000 in Q2 2023 from the same period last year, while for Jun 2023 it was $95,000, marking a year-over-year decrease of 82.28%. This contributed to the annual value of $236,000 for FY2023, which is 134.30% up from last year.
  • Seres Therapeutics' Amortizatization of Intangibles amounted to $236,000 in FY2023, which was up 134.30% from -$688,000 recorded in FY2022.
  • In the past 5 years, Seres Therapeutics' Amortizatization of Intangibles registered a high of $236,000 during FY2023, and its lowest value of -$688,000 during FY2022.
  • Its 3-year average for Amortizatization of Intangibles is -$316,667, with a median of -$498,000 in 2021.
  • Per our database at Business Quant, Seres Therapeutics' Amortizatization of Intangibles crashed by 359.30% in 2020 and then skyrocketed by 134.30% in 2023.
  • Over the past 5 years, Seres Therapeutics' Amortizatization of Intangibles (Yearly) stood at $172,000 in 2019, then crashed by 359.30% to -$446,000 in 2020, then declined by 11.66% to -$498,000 in 2021, then tumbled by 38.15% to -$688,000 in 2022, then skyrocketed by 134.30% to $236,000 in 2023.